These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy. Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833 [TBL] [Abstract][Full Text] [Related]
5. [TNFα blocking agents and sarcoidosis: an update]. Toussirot E; Pertuiset E Rev Med Interne; 2010 Dec; 31(12):828-37. PubMed ID: 20510487 [TBL] [Abstract][Full Text] [Related]
6. [Nasosinusal and cervical sarcoidosis: a case series of three patients and literature review]. Hermet M; le Guenno G; Rieu V; Philippe P; Ruivard M Rev Med Interne; 2012 Jan; 33(1):46-9. PubMed ID: 21601318 [TBL] [Abstract][Full Text] [Related]
7. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review. Massara A; Cavazzini L; La Corte R; Trotta F Semin Arthritis Rheum; 2010 Feb; 39(4):313-9. PubMed ID: 19147181 [TBL] [Abstract][Full Text] [Related]
11. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy. Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903 [TBL] [Abstract][Full Text] [Related]
12. Systemic sarcoidosis reactions as a result of tumour necrosis factor-alpha treatment for patients with psoriasis. Bewley AP; Maleki S Clin Exp Dermatol; 2021 Dec; 46(8):1548-1550. PubMed ID: 34021925 [TBL] [Abstract][Full Text] [Related]
13. [Successful treatment with infliximab of a patient with refractory sarcoidosis]. Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311 [TBL] [Abstract][Full Text] [Related]
14. [Pulmonary sarcoidosis developing during treatment with etanercept]. Kerjouan M; Jouneau S; Lena H; Luraine R; Desrues B; Delaval P Rev Mal Respir; 2011 Mar; 28(3):360-4. PubMed ID: 21482342 [TBL] [Abstract][Full Text] [Related]
15. Infliximab for treating sarcoidosis patients, Portuguese experience. Aguiar M; Marçal N; Mendes AC; Bugalho de Almeida A Rev Port Pneumol; 2011; 17(2):85-93. PubMed ID: 21477572 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases. Dhaille F; Viseux V; Caudron A; Dadban A; Tribout C; Boumier P; Clabaut A; Lok C Dermatology; 2010; 220(3):234-7. PubMed ID: 20185892 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary sarcoidosis. Baughman RP Clin Chest Med; 2004 Sep; 25(3):521-30, vi. PubMed ID: 15331189 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab. Almodóvar R; Izquierdo M; Zarco P; Javier Quirós F; Mazzucchelli R; Steen B Clin Exp Rheumatol; 2007; 25(1):99-101. PubMed ID: 17417999 [TBL] [Abstract][Full Text] [Related]
19. Sarcoidosis-like granulomatosis of the hypopharynx as a complication of anti-TNF therapy. Christoforidou A; Goudakos J; Bobos M; Lefkaditis E; Vital V; Markou K Am J Otolaryngol; 2013; 34(3):268-72. PubMed ID: 23357593 [TBL] [Abstract][Full Text] [Related]